NOVONESIS (NOVOZYMES) B financial statements, including revenue, expenses, profit, and loss
The total revenue of NSIS/N for the last quarter is 11.57 B MXN, and it's 5.37% higher compared to the previous quarter. The net income of Q4 23 is 1.75 B MXN.